708(top 15%)
articles
27.8K(top 10%)
citations
145(top 14%)
★★ articles
4(top 13%)
★★★ articles
1.5(top 49%)
Avg IF
84(top 8%)
H-Index
141(top 9%)
G-Index
267
journals

Most Cited Articles of Princess Margaret Hospital in 2009

TitleJournalYearCitations
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAilJournal of Clinical Oncology20091.2K
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studiesOncologist2009591
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphomaJournal of Clinical Oncology2009538
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancerJournal of Clinical Oncology2009533
Dose escalation methods in phase I cancer clinical trialsJournal of the National Cancer Institute2009528
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaLeukemia2009356
Phase I study of individualized stereotactic body radiotherapy of liver metastasesJournal of Clinical Oncology2009352
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancerJournal of Thoracic Oncology2009350
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association studyNature Genetics2009325
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlasInternational Journal of Radiation Oncology Biology Physics2009320
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myelomaLeukemia2009307
Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial designClinical Breast Cancer2009303
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trialLeukemia2009281
Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRIJournal of Magnetic Resonance Imaging2009278
The EGFRvIII variant in glioblastoma multiformeJournal of Clinical Neuroscience2009276
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinomaJournal of Clinical Oncology2009255
Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studiesCancer2009253
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guidelineBritish Journal of Haematology2009252
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemiaBlood2009238
The tumor microenvironment and metastatic diseaseClinical and Experimental Metastasis2009232
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?Annals of Oncology2009222
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissuesLaboratory Investigation2009205
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generationProceedings of the National Academy of Sciences of the United States of America2009198
Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastasesInternational Journal of Radiation Oncology Biology Physics2009197
The management of thymoma: a systematic review and practice guidelineJournal of Thoracic Oncology2009193